CRX can be given to a patient suffering from lung cancer. The innate immune activating agent will probably provide protection against biothreat pathogen spectrum for 2 to 14 days. For IFN’s it can go upto 26 weeks.

TAGS: 1. pneumonia lung cancer diagnosis
2. diagnosis code lung cancer
3. living diagnosis lung cancer
4. lung cancer diagnosis rate
5. secondary lung cancer diagnosis